about
Hepatitis G virus infection in fulminant hepatic failureRates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.Underestimation of chronic renal dysfunction after liver transplantation: ICEBERG study.Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review.[Abdominal pseudotumor and Whipple's disease]Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy.Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications.Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV.Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.Validity of the Spanish 8-item short-form generic health-related quality-of-life questionnaire in surgical patients: a population-based study.Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study.Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study.Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study.Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: a retrospective observational study[Sociosanitary impact on patients with rare diseases (ERES study)][Prophylactic sclerosis of esophageal varices. Results of a controlled prospective study]Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitisThe relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysisAsthma control in Spain. Do season and treatment pattern matter? The ESCASE studyRespiratory infection in congenital cardiac disease. Hospitalizations in young children in Spain during 2004 and 2005: the CIVIC Epidemiologic StudyDoes physical activity modify the association between body mass index and colorectal adenomas?[Quality of life specific questionnaire for constipated patients: development and validation of CVE-20][Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease]Reply
P50
Q27480284-36372042-A994-45F4-B65B-F7461BBFBE76Q33424090-06FCBF4D-E47D-46ED-BE1E-343115F57AB8Q35210723-DDD293F5-DE7C-44A6-95AF-0881F91DC8ACQ36103128-E5E14722-D585-4C73-8E6E-27F68061DB79Q40668994-71267885-8AF8-461F-94E0-C89EEB89A9D4Q41728363-50024877-BE69-4773-9031-D830B2415733Q42982511-838BF8E7-39B0-44D1-85EC-6D66898ECBAEQ42983090-BF1FA97E-53CF-4078-8039-739A41DC2E05Q42992257-1D97BFA3-81A2-4BC3-A68E-0BC32BC9EF1AQ42997658-1347C8E1-ECE9-46B5-81DA-33A694BE67D9Q43753027-82DDC347-202F-4528-BD17-1A63D91D0079Q45398497-CD2F4E30-4A9B-4CF6-97C8-BB89D52F1453Q46911854-7AA45F7C-5DC1-4A62-8FD9-D7B0537C3D8AQ51102173-FB210F9C-2A56-4E57-9164-34D2166E5D2FQ51103817-36E134E6-9B3C-442D-8792-B32D79EAAF17Q52400280-27521307-6C1D-41C6-AAEF-8717BF2D093DQ58840831-B15F5387-3F84-4175-B6E4-D763FE2E0060Q64045284-3259D009-36D5-4787-B10E-E7018D92E85CQ70164893-5253E0F3-C5C3-42A9-A6BF-DCD7718D486CQ70539279-471AD681-3E51-40C2-8217-4DEF5D6EE20AQ70677049-0EB4E086-2A98-4834-8D12-A7DFDFA2F177Q79322502-01D3B504-3D20-49E4-80FC-854001417694Q80698265-92ECE52A-5F3B-490E-BF79-99BA460A7B74Q81698183-52199612-91FC-4766-8844-13FA87906212Q82238909-1A0B413A-0BC4-4635-9C30-C2006E4D28FAQ82430920-BAF3497F-A89D-4FFD-95A3-5F9D0A5B35D2Q95442776-1C9DFFE4-959D-4133-95C6-D201602D4C13
P50
description
researcher
@en
wetenschapper
@nl
name
Guilera M
@ast
Guilera M
@nl
Magda Guilera
@en
type
label
Guilera M
@ast
Guilera M
@nl
Magda Guilera
@en
prefLabel
Guilera M
@ast
Guilera M
@nl
Magda Guilera
@en
P106
P31
P496
0000-0002-7594-5282